Julie Cardoso: FDA Clears the First AI-Guided Ultrasound Software for Suspected DVT
Julie Cardoso, Owner and Executive Director of Independent Diagnostic Testing Facility at Universal Ultrasound Diagnostics, shared a post on LinkedIn:
“Huge milestone for our team at ThinkSono: the FDA has granted clearance for ThinkSono Guidance.
It’s the first AI-powered ultrasound guidance software cleared for the evaluation of suspected deep vein thrombosis (DVT).
What this means in practice: a nurse or clinician with 60–90 minutes of training can capture a vascular ultrasound exam at the bedside, guided in real time by our AI, with every exam reviewed remotely by a qualified interpreting physician.
Faster answers for patients, wherever they present.
It took a decade of work, 1,691 patients across 24 study sites, and an incredible team to get here. Proud to be part of it!”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Aug 26, 2026, 03:46Hugo Ribeiro: Which NSAIDs Are Safest for Older Adults?
-
Aug 25, 2026, 19:45Cara T. Hoepner: Omega-3 is Not an Exposure
-
Aug 25, 2026, 19:42Mark Skinner Honored With the Lifetime Achievement Award – National Bleeding Disorders Foundation
-
Aug 25, 2026, 19:41Katrina Snow: Honoured to Share NYG’s Ongoing QI Work Focused on Transfusion Safety in SCD
-
Aug 25, 2026, 19:39José María López Alemany: Madrid Makes an Urgent Appeal for Blood Donation as Reserves Fall to 38%
-
Aug 25, 2026, 19:36Carlos Mirel Peñate: How Are We Actually Managing AF in ATTR-CM?
-
Aug 25, 2026, 19:35Kelly Anderson: Anticoagulation and Cognitive Health in Older Adults With AF and Alzheimer’s Disease
-
Aug 25, 2026, 19:34Uriel Suárez: Managing Anticoagulation in Patients With Brain Metastases
-
Aug 25, 2026, 19:33Ali Moradi: Excited to Present Two Abstracts at AHA 2026